Futura Medical plc (LON:FUM - Get Free Report)'s share price crossed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of GBX 36.09 ($0.47) and traded as low as GBX 32.85 ($0.43). Futura Medical shares last traded at GBX 33.30 ($0.43), with a volume of 104,440 shares trading hands.
Futura Medical Price Performance
The stock has a market capitalization of £100.09 million, a P/E ratio of -3,310.00 and a beta of 1.25. The firm has a 50-day simple moving average of GBX 34.84 and a 200 day simple moving average of GBX 36.04.
Insider Activity
In other news, insider James Henry Barder sold 250,000 shares of the stock in a transaction dated Friday, September 13th. The stock was sold at an average price of GBX 41 ($0.53), for a total value of £102,500 ($133,082.32). Insiders own 32.14% of the company's stock.
About Futura Medical
(
Get Free Report)
Futura Medical plc, a pharmaceutical company, develops pharmaceutical and healthcare products for the consumer healthcare markets focusing on sexual health and pain relief management. Its lead product is MED3000, a topical gel for the treatment of erectile dysfunction. The company also develops pain relief products, including TPR100, a topical diclofenac pain relief gel; CBD100, a topical cannabidiol formulation; and TIB200, a topical ibuprofen pain relief gel.
Featured Stories
Before you consider Futura Medical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Futura Medical wasn't on the list.
While Futura Medical currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
